Evidence map›Paper›PMID 28959620›Full record

ArticleToxicology reports2017

Ninety-day oral toxicity study of rice-derived γ-oryzanol in Sprague-Dawley rats.

Seol-Hee Moon, Duyeol Kim, Norihito Shimizu, Tadashi Okada, Shoketsu Hitoe, Hiroshi Shimoda

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Gamma-oryzanol dose optimization in maturation or culture media forIranian journal of veterinary research · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Seol-Hee MoonBiotoxtech Co., Ltd., 53, Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, 363-883, Republic of Korea.
Duyeol KimBiotoxtech Co., Ltd., 53, Yeongudanji-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, 363-883, Republic of Korea.
Norihito ShimizuOryza Oil & Fat Chemical Co. Ltd., 1 Numata, Kitagata-cho, Ichinomiya, Aichi 493-8001, Japan.
Tadashi OkadaOryza Oil & Fat Chemical Co. Ltd., 1 Numata, Kitagata-cho, Ichinomiya, Aichi 493-8001, Japan.
Shoketsu HitoeOryza Oil & Fat Chemical Co. Ltd., 1 Numata, Kitagata-cho, Ichinomiya, Aichi 493-8001, Japan.
Hiroshi ShimodaOryza Oil & Fat Chemical Co. Ltd., 1 Numata, Kitagata-cho, Ichinomiya, Aichi 493-8001, Japan.
Oryza (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 90-day oral toxicity study of γ-oryzanol, a rice-derived triterpenoid ferulate, was performed by oral gavage administration to male and female Sprague-Dawley rats at doses of 0, 1000, and 2000 mg/kg body weight/day. All rats administered γ-oryzanol survived throughout the study period. Both male and female rats showed no toxicologically significant changes of the general signs, examination findings, body weight, food consumption, functional observational battery results, ophthalmological findings, urinalysis, hematology tests, clinical chemistry tests, organ weights, and necropsy findings. Moreover, there were no histopathological changes related to administration of γ-oryzanol in males and females from the 2000 mg/kg body weight/day group. In conclusion, the no observed adverse effect level (NOAEL) of γ-oryzanol exceeded 2000 mg/kg body weight/day for both male and female rats under the conditions of this study.

Indexed as

NOAELRatRepeated-dose oral toxicity studyRiceγ-Oryznaol

Identifiers

PMID28959620
PMCPMC5615091
OpenAlexW2560137260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.